|
|
||||||||
Departments of Radiology and Nuclear Medicine and Surgical Neurology, Research Institute of Brain and Blood Vessels, Akita, Japan
Department of Neurosurgical Service, Akita University School of Medicine, Akita, Japan
Correspondence: For correspondence or reprints contact: T. Ogawa, Department of Radiology and Nuclear Medicine, Research Institute of Brain and Blood Vessels-Akita, 6-10, Senshu-kubota-machi, Akita City, 010, Akita, Japan.
ABSTRACT
We evaluated whether PET with L-methyl-11C-methionine (11C-methionine) was clinically useful in distinguishing neoplastic from non-neoplastic intracerebral hematoma. Methods: We examined eight patients with neoplastic (n = 4) or non-neo plastic (n = 4) intracerebral hematomas between 5 and 68 days after the bleeding episode using PET with 11C-methionine (Met-PET). Results: Carbon-11-methionine accumulated in the area surrounding the hematoma in both groups, except in one patient with an acute hypertensive hematoma. Between 22 and 45 days after the ictus, non-neoplastic hematomas showed increased 11C-methionine accumulation largely in accordance with the contrast-enhanced areas on CT or MR images; whereas between 14 and 68 days after bleeding, neoplastic hematomas showed increased 11C-methionine accumulation that extended beyond the contrast-enhanced areas on CT or MR images. The intensity 11C-methionine accumulation in tumor tissue was greater than that in non-neoplastic hematomes. Conclusion: Preliminary results suggest that Met-PET can distinguish neoplastic from non-neoplastic hematomas on the basis of differences in lesion extent compared with CT or MR findings.
Key Words: positron emission tomography carbon-11-methionine intracerebral hematoma brain tumor
This article has been cited by other articles:
![]() |
D. A. Hammoud, J. M. Hoffman, and M. G. Pomper Molecular Neuroimaging: From Conventional to Emerging Techniques Radiology, October 1, 2007; 245(1): 21 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Minutoli, F. F. Angileri, A. Conti, A. Herberg, D. Arico, S. Baldari, S. Cardali, O. de Divitiis, A. Germano, and S. Baldari Timing of Examination Affects Reliability of 99mTc-Methoxyisobutylisonitrile SPECT in Distinguishing Neoplastic from Nonneoplastic Brain Hematomas J. Nucl. Med., April 1, 2005; 46(4): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Minutoli, F. F. Angileri, S. Cosentino, G. R. Pecorella, S. Cardali, O. De Divitiis, A. Germano, and S. Baldari 99mTc-MIBI SPECT in Distinguishing Neoplastic from Nonneoplastic Intracerebral Hematoma J. Nucl. Med., October 1, 2003; 44(10): 1566 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Schellinger, J. B. Fiebach, K. Hoffmann, K. Becker, B. Orakcioglu, R. Kollmar, E. Juttler, P. Schramm, S. Schwab, K. Sartor, et al. Stroke MRI in Intracerebral Hemorrhage: Is There a Perihemorrhagic Penumbra? Stroke, July 1, 2003; 34(7): 1674 - 1679. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |